検索結果 - "Major depressive disorder"

提案スペルによる検索:

結果の絞り込み
  1. 1

    Major depressive disorder and the microbiome-gut-brain axis 著者: F. H. Ouriaghli, I. A. Elhaty

    出版事項 2025-04-01

    The central nervous system and the gastrointestinal tract are connected bidirectionally via the gut-brain axis (GBA). According to the gut microbiota hypothesis, changes in the composition and activity of the gut microbiota can affect the GBA, contributing to the onset of mental illnesses such as de...

    詳細記述

    主題: 全文の入手
    論文
  2. 2
  3. 3

    Comprehensive Characterization of Antidepressant Pharmacogenetics: A Systematic Review of Studies in Major Depressive Disorder 著者: Caroline W. Grant, Karina Delaney, Linsey E. Jackson, Justin Bobo, Leslie C. Hassett, Liewei Wang, Richard M. Weinshilboum, Paul E. Croarkin, Melanie T. Gentry, Ann M. Moyer, Arjun P. Athreya

    出版事項 2025-06-01

    ABSTRACT Pharmacogenetics is a promising strategy to facilitate individualized care for patients with Major Depressive Disorder (MDD). Research is ongoing to identify the optimal genetic markers for predicting outcomes to antidepressant therapies. The primary aim of this systematic review was to sum...

    詳細記述

    主題: “…major depressive disorder…”
    全文の入手
    論文
  4. 4

    Deciphering transcriptomic signatures in schizophrenia, bipolar disorder, and major depressive disorder 著者: Priyanka, Rajesh Kumar, Vinod Kumar, Ashwani Kumar, Sandeep Singh Rana

    出版事項 2025-07-01

    Schizophrenia (SCZ), Bipolar Disorder (BD), and Major Depressive Disorder (MDD) are severe psychiatric conditions that share overlapping clinical symptoms, yet they differ in their underlying molecular mechanisms. Despite extensive research, the biological foundations of these disorders remain incom...

    詳細記述

    主題: 全文の入手
    論文
  5. 5

    Epidemiology of major depressive disorder in mainland china: a systematic review. 著者: Lian Gu, Juanjuan Xie, Jianxiong Long, Qing Chen, Qiang Chen, Runde Pan, Yan Yan, Guangliang Wu, Baoyun Liang, Jinjing Tan, Xinfeng Xie, Bo Wei, Li Su

    出版事項 2013-01-01

    <h4>Background</h4>Major depressive disorder (MDD) is one of the important causes of disease burden in the general population. Given the experiencing rapid economic and social changes since the early 1990s and the internationally recognized diagnostic criteria and interview instruments a...

    詳細記述

    “…<h4>Background</h4>Major depressive disorder (MDD) is one of the important causes of disease burden in the general population. …”
    全文の入手
    論文
  6. 6

    The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials 著者: Li G, Wang X, Ma D

    出版事項 2016-02-01

    Guangjian Li, Xu Wang, Dihui Ma Department of Neurology and Neuroscience Center, First Hospital of Jilin University, Changchun, People&amp;rsquo;s Republic of China Background: Vortioxetine is an investigational multimodal antidepressant. We conducted this meta-analysis to assess the efficacy...

    詳細記述

    主題: 全文の入手
    論文
  7. 7

    Medication non-adherence in depression: a systematic review and metanalysis 著者: Roseane Dorte Halkjaer-Lassen, Walter S. Gonçalves, Bruno R. Gherman, Evandro S. F. Coutinho, Antonio E. Nardi, Maria A. A. Peres, José Carlos Appolinario

    出版事項 2025-07-01

    Abstract Objective: Medication non-adherence is frequently reported in patients with major depressive disorder (MDD). The objective of this review is to consolidate data on the prevalence of non-adherence to antidepressant in MDD. Methods: A systematic review with meta-analysis was performed accor...

    詳細記述

    主題: 全文の入手
    論文
  8. 8

    5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients 著者: Dong Z, Li X, He L, He G, Yu T, Sun X

    出版事項 2016-07-01

    Zai-Quan Dong,1,* Xi-Rong Li,2,* Lin He,3,4 Guang He,3,4 Tao Yu,3,4 Xue-Li Sun1 1Psychological Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 2Mental Health Center, First Affiliated Hospital, Chongqing Medical University, Chongqing, 3Bio-X Institutes, Key Laboratory for the Gene...

    詳細記述

    主題: 全文の入手
    論文
  9. 9

    The Role of Vitamin D in the Management of Major Depressive Disorder: A Systematic Review 著者: Andreea Roșian, Mihaela Zdrîncă, Luciana Dobjanschi, Laura Grațiela Vicaș, Mariana Eugenia Mureșan, Camelia Maria Dindelegan, Rita Ioana Platona, Eleonora Marian

    出版事項 2025-05-01

    <b>Background/Objective:</b> Depression is a widespread and complex disorder, constituting a major public health concern due to its significant impact on mental health. Because of the limitations of major depressive disorder (MDD) treatment, recent research on depression management has f...

    詳細記述

    主題: 全文の入手
    論文
  10. 10

    Implications of the choice of method to identify major depressive disorder in large research cohorts 著者: Jorge A. Sanchez-Ruiz, Nicolas A. Nuñez, Gregory D. Jenkins, Brandon J. Coombes, Lauren A. Lepow, Braja Gopal Patra, Ardesheer Talati, Mark Olfson, J. John Mann, Myrna M. Weissman, Jyotishman Pathak, Alexander Charney, Euijung Ryu, Joanna M. Biernacka

    出版事項 2025-09-01

    Background: Clinical heterogeneity and variations in methods to identify major depressive disorder (MDD) across studies compromise replicability of research findings. This study evaluated potential implications of different MDD case definitions in a large biobank cohort. Methods: Among Mayo Clinic B...

    詳細記述

    “…Background: Clinical heterogeneity and variations in methods to identify major depressive disorder (MDD) across studies compromise replicability of research findings. …”
    全文の入手
    論文
  11. 11

    Economic costs associated with insomnia in adults with subthreshold depression or major depressive disorder 著者: Phuong Hong Le, Long Khanh-Dao Le, Joahna Kevin Perez, Shantha M. W. Rajaratnam, Cathrine Mihalopoulos

    出版事項 2025-07-01

    Background Previous studies have found substantial costs to be associated with depression and insomnia (as separate entities). Aims To estimate healthcare service use and costs associated with insomnia in Australian adults experiencing subthreshold depression or major depressive disorder (MDD)....

    詳細記述

    “…Aims To estimate healthcare service use and costs associated with insomnia in Australian adults experiencing subthreshold depression or major depressive disorder (MDD). Method Healthcare service use and productivity loss were extracted from the cross-sectional 2020–2022 National Survey of Mental Health and Wellbeing data. …”
    全文の入手
    論文
  12. 12

    The effects of cognitive therapy versus 'treatment as usual' in patients with major depressive disorder. 著者: Janus Christian Jakobsen, Jane Lindschou Hansen, Ole Jakob Storebø, Erik Simonsen, Christian Gluud

    出版事項 2011-01-01

    <h4>Background</h4>Major depressive disorder afflicts an estimated 17% of individuals during their lifetimes at tremendous suffering and costs. Cognitive therapy may be an effective treatment option for major depressive disorder, but the effects have only had limited assessment in system...

    詳細記述

    “…<h4>Background</h4>Major depressive disorder afflicts an estimated 17% of individuals during their lifetimes at tremendous suffering and costs. …”
    全文の入手
    論文
  13. 13

    Symptom networks in major depressive disorder and treatment response: special focus on TRD 著者: Alexander Kautzky, Lucie Bartova, Markus Dold, Daniel Souery, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz, Chiara Fabbri, Alessandro Serretti, Evgenii Tretiakov, Dan Rujescu, Tibor Harkany, Siegfried Kasper

    出版事項 2025-01-01

    Abstract Background Heterogeneous symptoms in major depression contribute to unsuccessful antidepressant treatment, termed treatment-resistant depression (TRD). Psychometric network modeling conceptualizes depression as interplay of symptoms with potential benefits for treatment; however, a knowledg...

    詳細記述

    主題: “…major depressive disorder…”
    全文の入手
    論文
  14. 14

    The experiences of mental healthcare users regarding the quality of their major depressive disorder treatment 著者: Frans M. Lekoloane, Marang T. Mamahlodi

    出版事項 2025-07-01

    Background: Millions of people worldwide are affected by major depressive disorder (MDD). However, those with MDD do not receive treatment. More studies have been conducted on the efficacy of medications rather than the subjective experiences of mental healthcare users (MHCUs). Aim: This study was...

    詳細記述

    主題: “…major depressive disorder…”
    全文の入手
    論文
  15. 15

    Identification of Genes in Diagnosing Major Depressive Disorder with Anorexia Through Bioinformatics Analysis 著者: Guo F, Li Y, Cheng J, Wang X, Hu W, Zhang K, Jing X, Xing J, Liu Z, Zhang H, Liu P

    出版事項 2025-07-01

    Fengtao Guo,1,2 Ying Li,2,3 Junxiang Cheng,1,2 Xinxia Wang,1,2 Wei Hu,1,2 Kun Zhang,4 Xushu Jing,1,2 Jinrui Xing,1,2 Zhifen Liu,1 Huanhu Zhang,2,5 Penghong Liu1,2 1Department of Psychiatry, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China; 2Shanxi Medical Univ...

    詳細記述

    主題: “…Major depressive disorder,Anorexia,Inflammation,Bioinformatics analysis…”
    全文の入手
    論文
  16. 16

    Common Metabolomic Changes in Various Drug Treatments for Major Depressive Disorder Are Related to Purine Metabolism 著者: Seungyeon LEE, Jiyeong LEE

    出版事項 2025-06-01

    Various factors influence the pathogenesis of major depressive disorder (MDD). Its heterogeneous nature complicates the identification of underlying biological mechanisms, limiting diagnostic and therapeutic advances. Stratifying MDD patients into biologically distinct subgroups and identifying shar...

    詳細記述

    主題: “…drug treatment; inosine; major depressive disorder; metabolomics…”
    全文の入手
    論文
  17. 17

    Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder 著者: Harada E, Shirakawa O, Satoi Y, Marangell L, Escobar R

    出版事項 2016-01-01

    Eiji Harada,1 Osamu Shirakawa,2 Yoichi Satoi,3 Lauren B Marangell,4 Rodrigo Escobar5 1Eli Lilly Japan K.K., Medicines Development Unit Japan, Medical Science, Kobe, 2Department of Neuropsychiatry, Kinki University Faculty of Medicine, Osakasayama, 3Eli Lilly Japan K.K., Medicines Development Unit J...

    詳細記述

    主題: 全文の入手
    論文
  18. 18

    Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data 著者: Solem CT, Shelbaya A, Wan Y, Deshpande CG, Alvir J, Pappadopulos E

    出版事項 2016-10-01

    Caitlyn T Solem,1 Ahmed Shelbaya,2,3 Yin Wan,1 Chinmay G Deshpande,1 Jose Alvir,2 Elizabeth Pappadopulos2 1Pharmerit International, Real World Evidence/Data Analytics, Bethesda, MD, 2Pfizer, Inc., Global Health Outcomes, New York, NY, 3Epidemiology Department of Mailman&amp;rsquo;s School of Pu...

    詳細記述

    主題: “…Major depressive disorder…”
    全文の入手
    論文
  19. 19

    Suicide attempts in elderly Han Chinese patients with major depressive disorder: prevalence and associated factors 著者: Xiaofan Zhou, Yu Zhou, Xiang Yang Zhang

    出版事項 2025-09-01

    Objective: Suicide attempts (SA) are common in elderly patients with major depressive disorder (MDD), but few studies have focused on the prevalence and associated factors in elderly Chinese Han patients with MDD. Method: A total of 266 first episode and drug naïve older patients with MDD (age ≥ 50 ...

    詳細記述

    主題: “…Major depressive disorder…”
    全文の入手
    論文
  20. 20

    Investigating Psychiatric Disorders in Patients with Suicide Attempt 著者: Zoha Sadeghian, Parvane Rashidpour, Hamidreza Ghasemirad, Seyed Mojtaba Yassini Ardekani, Shahab ali Shirkhoda, Golraste Kholasezade, Hamid Owliaey, Reza Bidaki

    出版事項 2024-05-01

    Background: Attempting suicide is considered one of the important indicators of the mental health of individuals in society. One of the important issues in suicide is psychiatric disorders and related factors. Given that no comprehensive study was conducted in Yazd province, this study aimed to asse...

    詳細記述

    主題: 全文の入手
    論文